Scientific Sessions 2025  /  TCT at AHA: Heart Team in Action: Arrhythmogenic Mitral Valve Prolapse: Predicting Risk, Protecting Patients, and Personalizing Treatment  /  Mitral Valve Surgery in Arrhythmogenic Mitral Regurgitation: Special Considerations
Logo

American Heart Association

  85
  0

Final ID:

Mitral Valve Surgery in Arrhythmogenic Mitral Regurgitation: Special Considerations

  • Borger, Michael  ( Leipzig Heart Center , Leipzig , Germany )
  • Adams, David  ( MOUNT SINAI MEDICAL CENTER , New York , New York , United States )
  • Gillinov, A Marc  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Nguyen, Tom  ( Miami Cardiac and Vascular Inst , Miami , Florida , United States )
  • Ramzy, Danny  ( UTHealth Houston , Houston , Texas , United States )
    • Author Disclosures:
    Michael Borger: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Edwards Lifesciences -- my hospital receives speakers' honoria and/or consulting fees on my behalf:Active (exists now) ; Other (please indicate in the box next to the company name):Artivion -- my hospital receives speakers' honoria and/or consulting fees on my behalf:Active (exists now) ; Other (please indicate in the box next to the company name):Abbott -- my hospital receives speakers' honoria and/or consulting fees on my behalf:Active (exists now) ; Other (please indicate in the box next to the company name):Medtronic -- my hospital receives speakers' honoria and/or consulting fees on my behalf:Active (exists now) | David Adams: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Edwards Lifesciences, Medtronic:Active (exists now) | A MARC GILLINOV: No Answer | Tom Nguyen: DO NOT have relevant financial relationships | Danny Ramzy: DO have relevant financial relationships ; Speaker:Abiomed:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Heart Team in Action: Arrhythmogenic Mitral Valve Prolapse: Predicting Risk, Protecting Patients, and Personalizing Treatment

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
EP Assessment of Arrhythmias and SCD Risk

Chugh Sumeet, Albert Christine

Arrhythmogenic Mitral Valve Prolapse: Definition, Prevalence, Prognosis, and How to Predict
Sudden Death

Basso Cristina, Perazzolo Marra Martina, Enriquez-sarano Maurice, Michelena Hector

More abstracts from these authors:
Case Presentation of Arrythmic Mitral Valve Prolapse

Costa Ana Claudia, Adams David, Nguyen Tom, Ramzy Danny

Surgical Advances: Minimally Invasive and Robotic Mitral Repair is PrimeTime

Ramzy Danny, Mick Stephanie, Gillinov A Marc, Nguyen Tom

You have to be authorized to contact abstract author. Please, Login
Not Available